title: Abciximab: IIb or not IIb, is that still the question?
authors.forename: Sundip
authors.initials: S
authors.lastname: Patel
authors.forename: Divaka
authors.initials: D
authors.lastname: Perera
authors.forename: Simon
authors.initials: S
authors.lastname: Redwood
mesh_terms: D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*
chemical_list: D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077284:Abciximab